Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Shareholders Equity (Quarterly): -343.71M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -343.71M |
| June 30, 2024 | -605.92M |
| March 31, 2024 | -658.82M |
| December 31, 2023 | -932.49M |
| September 30, 2023 | -660.85M |
| June 30, 2023 | -478.54M |
| Date | Value |
|---|---|
| March 31, 2023 | -655.77M |
| December 31, 2022 | -564.42M |
| September 30, 2022 | -277.23M |
| June 30, 2022 | -296.22M |
| December 31, 2021 | -135.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-932.49M
Minimum
Dec 2023
-135.61M
Maximum
Dec 2021
-509.96M
Average
-564.42M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Procaps Group SA | 39.39M |
| Johnson & Johnson | 70.16B |
| Pfizer Inc | 92.29B |
| Rigel Pharmaceuticals Inc | -14.64M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Total Liabilities (Quarterly) | 1.577B |
| Debt to Equity Ratio | -2.991 |
| Current Ratio | 2.694 |
| Net Debt Paydown Yield | -1.22% |